CytomX Therapeutics
CTMX
#9040
Rank
โ‚ฌ82.02 M
Marketcap
1,05ย โ‚ฌ
Share price
0.00%
Change (1 day)
-21.92%
Change (1 year)

EPS for CytomX Therapeutics (CTMX)

EPS in 2023 (TTM): -0,81ย โ‚ฌ

According to CytomX Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,81ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,64ย โ‚ฌ an increase over its 2021 EPS that were of -1,75ย โ‚ฌ.

EPS history for CytomX Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,81ย โ‚ฌ-50.63%
2022-1,64ย โ‚ฌ-6.04%
2021-1,75ย โ‚ฌ30.94%
2020-1,34ย โ‚ฌ-52.56%
2019-2,82ย โ‚ฌ45.05%
2018-1,94ย โ‚ฌ72.65%
2017-1,13ย โ‚ฌ-27.78%
2016-1,56ย โ‚ฌ35.65%
2015-1,15ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-2,10ย โ‚ฌ 159.52%๐Ÿ‡บ๐Ÿ‡ธ USA